Trial Details

COMPLETED
Basic Information
Clinical ID c4322
Identifier NCT00705614
Trial Title Postmarketing Safety Surveillance European Registry of Crohn's Disease Patients Treated With Remicade or Standard Therapy (MK-2155-035)
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Crohn's Disease
Interventions BIOLOGICAL: Remicade
Participant Information
Sponsor Merck Sharp & Dohme LLC
City -
Country/Region -
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2003-07
Primary Completion Date 2013-02
Completion Date 2013-02